Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer

Abstract Background Though the gut microbiome has been associated with efficacy of immunotherapy (ICI) in certain cancers, similar findings have not been identified for microbiomes from other body sites and their correlation to treatment response and immune related adverse events (irAEs) in lung can...

Full description

Bibliographic Details
Main Authors: Justin Chau, Meeta Yadav, Ben Liu, Muhammad Furqan, Qun Dai, Shailesh Shahi, Arnav Gupta, Keri Nace Mercer, Evan Eastman, Taher Abu Hejleh, Carlos Chan, George J. Weiner, Catherine Cherwin, Sonny T. M. Lee, Cuncong Zhong, Ashutosh Mangalam, Jun Zhang
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Cancer
Subjects:
Immunotherapy
Immune checkpoint
Microbiome
Lung cancer
Adverse effects
Toxicity
Online Access:https://doi.org/10.1186/s12885-021-08530-z

Internet

https://doi.org/10.1186/s12885-021-08530-z

Similar Items